Haemophilus b conjugate (prp-omp) vaccine Pregnancy and Breastfeeding Warnings
Brand names: Liquid PedvaxHIB
Medically reviewed by Drugs.com. Last updated on Dec 4, 2023.
Haemophilus b conjugate (prp-omp) vaccine Pregnancy Warnings
Safety has not been established. This vaccine is only approved for use in young children.
US FDA pregnancy category: C
Animal studies are not available. There are no controlled data in human pregnancy.
US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.
Haemophilus b conjugate (prp-omp) vaccine Breastfeeding Warnings
This vaccine is only approved for use in young children.
Excreted into human milk: Data not available
Excreted into animal milk: Data not available
See also
References for pregnancy information
- (2022) "Product Information. Liquid PedvaxHIB (haemophilus b conjugate (PRP-OMP) vaccine)." Merck & Co., Inc
References for breastfeeding information
- (2022) "Product Information. Liquid PedvaxHIB (haemophilus b conjugate (PRP-OMP) vaccine)." Merck & Co., Inc
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
